The translational research working group developmental pathways: Introduction and overview

Clinical Cancer Research

Volumn 14, Issue 18, 2008, Pages 5664-5671

  Hawk, Ernest T ^a,b,g   Matrisian, Lynn M ^a,c   Nelson, William G ^a,d   Dorfman, Gary S ^a,e   Stevens, Lisa ^a,b   Kwok, Jennifer ^a,b   Viner, Jaye ^a,b   Hautala, Judith ^a,f   Grad, Oren ^a,f  

^a Translational Research Working Group

^b NATIONAL CANCER INSTITUTE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f Science and Technology Policy Institute   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; CANCER DIAGNOSIS; CANCER RESEARCH; HEALTH STATUS; HUMAN; IMMUNE RESPONSE; LIFESTYLE MODIFICATION; PRIORITY JOURNAL; REVIEW; ARTICLE; COMPUTER PROGRAM; GOVERNMENT; HEALTH CARE ORGANIZATION; MEDICAL RESEARCH; NEOPLASM; PROGRAM DEVELOPMENT; UNITED STATES;

BIOMEDICAL RESEARCH; GOVERNMENT PROGRAMS; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; PROGRAM DEVELOPMENT; SOFTWARE DESIGN; UNITED STATES;

EID: 53249111808     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1268     Document Type: Review

References (8)

1. Challenge and Opportunity on the Critical Path to New Medical Products. Food and Drug Administration, 2004 Mar. Available from: http://www.fda.gov/oc/ initiatives/criticalpath/whitepaper.pdf.
2. Transforming Translation - Harnessing Discovery for Patient and Public Benefit. Report of the TRWG of the National Cancer Advisory Board. Available from: http://www.cancer.gov/aboutnci/trwg/Order-final-report.
3. Dorfman GS, Sullivan DC, Schnall MD, Matrisian L, on behalf of the Translational Research Working Group. Translational Research Working Group developmental pathway for image-based assessment modalities. Clin Cancer Res 2008;14:5678-84.
4. Srivastava S, Gray JW, Reid BJ, Grad 0, Greenwood A, Hawk ET, on behalf of the Translational Research Working Group. Translational Research Working Group developmental pathway for biospecimen-based assessment modalities. Clin Cancer Res 2008;14: 5672-7.
5. Schilsky RL, Gordon G, GilmerTM, Courtneidge SA, Grad 0, Nelson WG, on behalf of the Translational Research Working Group. Translational Research Working Group developmental pathway for anticancer agents (Drugs or Biologies). Clin Cancer Res 2008;14:5685-91.
6. Cheever MA, Schlom J, Weiner LM, et al., on behalf of the Translational Research Working Group. Translational Research Working Group developmental pathway for immune response modifiers. Clin Cancer Res 2008;14: 5692-9.
7. Dorfman GS, Lawrence TS, Matrisian LM, for the Translational Research Working Group, Translational Research Working Group developmental pathway for interventive devices. Clin Cancer Res 2008;14:5700-6.
8. Hawk ET, Greenwood A, Gritz ER, et al., for the Translational Research Working Group. Translational Research Working Group developmental pathway for lifestyle alterations. Clin Cancer Res 2008;14: 5707-13.